A new technology is being hailed as a game-changer in the fight against womb cancer. The NHS has announced plans to implement an AI-powered blood test at several hospitals in England, aimed at detecting women who may have been referred for possible womb cancer before undergoing invasive checks.
According to The Guardian, around 90,000 postmenopausal women in England are referred by general practitioners (GPs) each year after experiencing heavy bleeding. However, many of these women would not be considered high-risk and therefore may only require a routine check-up. The AI blood test is designed to identify early signs of womb cancer in this group.
The implementation of the AI blood test is part of the NHS's efforts to reduce unnecessary invasive checks for women who are likely to have a benign condition. By screening women at an earlier stage, it could lead to more targeted and effective treatment plans. While the full impact of the technology has not yet been assessed, it is expected to make a significant difference in the fight against womb cancer.